Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Glulisine + Glargine in Type 1 Diabetes
NCT00397553Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jan 2005
- Primary completion
- Dec 2007
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of insulin glulisine in type 1 diabetes mellitus (T1D), sponsored by Sanofi. Started Jan 2005; status: completed.
02
Drugs
insulin glulisine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00397553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00397553.